Rafa Laboratories has received a potential $186 million contract from the Biomedical Advanced Research and Development Authority to develop an intramuscular formulation of tranexamic acid, or IM TXA, ...
This Phase 2 clinical study will evaluate paridiprubart (EB05) in hospitalized patients with acute respiratory distress syndrome (ARDS) due to a variety of causes. This BARDA-funded project is ...
The Department of Health and Human Services (HHS) has announced a plan to end mRNA vaccine work funded by the Biomedical Advanced Research and Development Authority (BARDA), a major escalation of ...
Looking to fill a treatment gap, the U.S. Biomedical Advanced Research and Development Authority (BARDA) is launching the first stage of a $100 million prize competition to support development of ...
(RTTNews) - OraSure Technologies, Inc. (OSUR), a medical device company, on Monday announced that it has secured funding from the U.S. Department of Health and Human Services' Biomedical Advanced ...
NEW YORK--(BUSINESS WIRE)--CastleVax, a clinical stage mucosal vaccine platform company, has received an additional Project NextGen award valued at approximately $34 million to support the continued ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results